Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
G Ital Dermatol Venereol ; 145(1): 1-5, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20197740

ABSTRACT

AIM: Observational study of all incident Tinea pedis cases, realised from 2001 to 2007 at the Dermatology Clinic of the University of Cagliari, Italy, which is the main reference centre for dermatologic diseases in central southern Sardinia. METHODS: All patients referred for foot inflammatory pathologies were included in the study. Samples of all clinically visible lesions were taken for mycological examination (20% KOH and culture). When lesions were absent samples were also taken from the IV inter-digital space of both feet to identify eventual sane carriers. Detailed anamneses investigated work, life habits, sports and predisposing conditions such as hyperhidrosis and previous pathologies of the feet. RESULTS: The study enrolled 1568 patients, of which 918 (510 male-408 female) presented clinical manifestations whereas other 650 (426 male-224 female) were asymptomatic. Tinea pedis was diagnosed in 232 (14.79%), 163 male-69 female aged between 11 and 78 years, all in the group with clinical manifestations. The identified dermatophytes were Trichophyton mentagrophytes 115 cases (49.56%), Trichophyton rubrum 110 cases (47.42%) and Epidermophyton floccosum 7 cases (3.08%). Mycological exams in patients without clinical signs were always negative for dermatophytes, while rare colonies of Candida albicans were identified in 3 cases (0.46%). CONCLUSION: Tinea pedis represents a common public health problem, which occurs mainly in male ageing from 16 to 45 years, when working and leisure activities are at their maximum. The absence of dermatophytes identification in 650 asymptomatic patients suggests that the sane carrier condition is a very rare event.


Subject(s)
Epidermophyton/isolation & purification , Tinea Pedis/diagnosis , Tinea Pedis/epidemiology , Trichophyton/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Incidence , Italy/epidemiology , Male , Middle Aged , Retrospective Studies , Risk Factors , Tinea Pedis/microbiology
2.
Cardiologia ; 35(12): 1015-22, 1990 Dec.
Article in Italian | MEDLINE | ID: mdl-2151370

ABSTRACT

To investigate the changes of electrocardiographic and echocardiographic indexes of left ventricular hypertrophy (LVH) during antihypertensive therapy, 100 hypertensive patients, mean age 46 years, were studied in pretreatment condition and during 12 months of antihypertensive therapy. In pretreatment condition, 83 patients showed LVH by echocardiography (echo; left ventricular mass index greater than 130 g/m2) and 30 patients had LVH by electrocardiography (ECG) (Sokolow index greater than 35 mm). In comparison to echo index of LVH, Sokolow index showed a sensibility of 34% and a specificity of 88%. Both LV mass echo index and ECG index significantly decreased after 3 months but in different way. LV mass index mainly decreased after 12 months, whereas Sokolow index particularly decreased after 6 months, with no further changes in the subsequent months. After 12 months of therapy, the LV mass echo index normalized in 19% of the patients (16/83) and Sokolow index normalized in 57% (17/30). ECG sensibility and specificity, in comparison to LV mass echo, was 20% and 100%, respectively. Thus, ECG appears less sensitive than echo in the detection of LVH. During antihypertensive therapy ECG index of LVH normalized more precociously and to a greater extent than the echo index. However, the normalization of LVH by ECG does not necessarily mean that a complete anatomic regression of LVH has occurred.


Subject(s)
Antihypertensive Agents/therapeutic use , Cardiomegaly/diagnosis , Echocardiography , Electrocardiography , Acebutolol/therapeutic use , Adolescent , Adult , Aged , Captopril/therapeutic use , Chlorthalidone/therapeutic use , Female , Humans , Hypertension/drug therapy , Indenes/therapeutic use , Male , Middle Aged , Nifedipine/therapeutic use , Oxprenolol/therapeutic use , Pindolol/therapeutic use , Propanolamines/therapeutic use , Timolol/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...